Similar articles for PMID: 29187890

Year	Number of Results
2002	2
2003	2
2004	3
2005	3
2006	5
2007	1
2008	3
2009	1
2010	5
2011	3
2012	2
2013	1
2014	1
2015	5
2016	10
2017	13
2018	7
2019	11
2020	3
2022	3
2023	2
2024	0

1

Decreased KPNB1 Expression is Induced by PLK1 Inhibition and Leads to Apoptosis in Lung Adenocarcinoma.

Sekimoto N, Suzuki Y, Sugano S. Sekimoto N, et al. J Cancer. 2017 Nov 6;8(19):4125-4140. doi: 10.7150/jca.21802. eCollection 2017. J Cancer. 2017. PMID: 29187890 Free PMC article.

2

MCC1019, a selective inhibitor of the Polo-box domain of Polo-like kinase 1 as novel, potent anticancer candidate.

Abdelfatah S, Berg A, Huang Q, Yang LJ, Hamdoun S, Klinger A, Greten HJ, Fleischer E, Berg T, Wong VKW, Efferth T. Abdelfatah S, et al. Acta Pharm Sin B. 2019 Sep;9(5):1021-1034. doi: 10.1016/j.apsb.2019.02.001. Epub 2019 Feb 10. Acta Pharm Sin B. 2019. PMID: 31649851 Free PMC article.

3

LSD1 Inhibition Attenuates Tumor Growth by Disrupting PLK1 Mitotic Pathway.

Dalvi PS, Macheleidt IF, Lim SY, Meemboor S, Müller M, Eischeid-Scholz H, Schaefer SC, Buettner R, Klein S, Odenthal M. Dalvi PS, et al. Mol Cancer Res. 2019 Jun;17(6):1326-1337. doi: 10.1158/1541-7786.MCR-18-0971. Epub 2019 Feb 13. Mol Cancer Res. 2019. PMID: 30760542

4

KPNB1 inhibition disrupts proteostasis and triggers unfolded protein response-mediated apoptosis in glioblastoma cells.

Zhu ZC, Liu JW, Li K, Zheng J, Xiong ZQ. Zhu ZC, et al. Oncogene. 2018 May;37(22):2936-2952. doi: 10.1038/s41388-018-0180-9. Epub 2018 Mar 9. Oncogene. 2018. PMID: 29520102 Free PMC article.

5

Epithelial-Mesenchymal Transition Predicts Polo-Like Kinase 1 Inhibitor-Mediated Apoptosis in Non-Small Cell Lung Cancer.

Ferrarotto R, Goonatilake R, Yoo SY, Tong P, Giri U, Peng S, Minna J, Girard L, Wang Y, Wang L, Li L, Diao L, Peng DH, Gibbons DL, Glisson BS, Heymach JV, Wang J, Byers LA, Johnson FM. Ferrarotto R, et al. Clin Cancer Res. 2016 Apr 1;22(7):1674-1686. doi: 10.1158/1078-0432.CCR-14-2890. Epub 2015 Nov 23. Clin Cancer Res. 2016. PMID: 26597303 Free PMC article.

6

Effect of antisense RNA targeting polo-like kinase 1 on cell cycle and proliferation in A549 cells.

Zhou Q, Bai M, Su Y. Zhou Q, et al. Chin Med J (Engl). 2004 Nov;117(11):1642-9. Chin Med J (Engl). 2004. PMID: 15569479

7

[Effect of antisense RNA targeting Polo-like kinase 1 on cell cycle of lung cancer cell line A549].

Zhou Q, Bai M, Su Y. Zhou Q, et al. Ai Zheng. 2005 Feb;24(2):149-54. Ai Zheng. 2005. PMID: 15694023 Chinese.

8

Targeting polo-like kinase 1 suppresses essential functions of alloreactive T cells.

Berges C, Chatterjee M, Topp MS, Einsele H. Berges C, et al. Immunol Res. 2016 Jun;64(3):687-98. doi: 10.1007/s12026-015-8778-2. Immunol Res. 2016. PMID: 26724940

9

Polo-like kinase (Plk)1 depletion induces apoptosis in cancer cells.

Liu X, Erikson RL. Liu X, et al. Proc Natl Acad Sci U S A. 2003 May 13;100(10):5789-94. doi: 10.1073/pnas.1031523100. Epub 2003 May 5. Proc Natl Acad Sci U S A. 2003. PMID: 12732729 Free PMC article.

10

Inhibition of Importin β1 With a 2-Aminothiazole Derivative Resulted in G₂/M Cell-cycle Arrest and Apoptosis.

Ha S, Choi J, Min NY, Lee KH, Ham SW. Ha S, et al. Anticancer Res. 2017 May;37(5):2373-2379. doi: 10.21873/anticanres.11575. Anticancer Res. 2017. PMID: 28476803

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

80 results

Results by year